Blair William & Co. IL boosted its holdings in Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) by 3.4% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 75,450 shares of the biotechnology company’s stock after purchasing an additional 2,486 shares during the quarter. Blair William & Co. IL owned about 0.10% of Axon Enterprise worth $23,607,000 at the end of the most recent quarter.
Other hedge funds have also bought and sold shares of the company. Vanguard Group Inc. increased its position in shares of Axon Enterprise by 0.5% during the fourth quarter. Vanguard Group Inc. now owns 7,930,905 shares of the biotechnology company’s stock worth $2,048,791,000 after acquiring an additional 40,435 shares in the last quarter. Sands Capital Management LLC raised its stake in shares of Axon Enterprise by 0.6% in the fourth quarter. Sands Capital Management LLC now owns 2,628,652 shares of the biotechnology company’s stock worth $679,060,000 after purchasing an additional 16,347 shares during the last quarter. Norges Bank bought a new position in shares of Axon Enterprise in the fourth quarter valued at approximately $195,406,000. Westfield Capital Management Co. LP boosted its position in shares of Axon Enterprise by 5.1% during the fourth quarter. Westfield Capital Management Co. LP now owns 731,721 shares of the biotechnology company’s stock valued at $189,025,000 after buying an additional 35,528 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its holdings in Axon Enterprise by 2.8% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 580,757 shares of the biotechnology company’s stock worth $150,027,000 after buying an additional 15,840 shares in the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.
Insider Activity
In other news, insider Jeffrey C. Kunins sold 43,668 shares of the firm’s stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $309.94, for a total value of $13,534,459.92. Following the completion of the transaction, the insider now directly owns 189,719 shares in the company, valued at $58,801,506.86. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In related news, insider Jeffrey C. Kunins sold 43,668 shares of the stock in a transaction on Thursday, May 9th. The stock was sold at an average price of $309.94, for a total value of $13,534,459.92. Following the sale, the insider now owns 189,719 shares in the company, valued at $58,801,506.86. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Jeri Williams sold 308 shares of the business’s stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $310.07, for a total value of $95,501.56. Following the transaction, the director now owns 1,607 shares of the company’s stock, valued at $498,282.49. The disclosure for this sale can be found here. Insiders have sold a total of 89,447 shares of company stock worth $27,684,677 over the last ninety days. Company insiders own 6.10% of the company’s stock.
Analyst Upgrades and Downgrades
Get Our Latest Report on Axon Enterprise
Axon Enterprise Stock Performance
AXON traded up $2.78 on Friday, hitting $308.45. The company’s stock had a trading volume of 268,835 shares, compared to its average volume of 488,986. Axon Enterprise, Inc. has a 12 month low of $175.37 and a 12 month high of $329.87. The firm has a market cap of $23.28 billion, a P/E ratio of 89.45 and a beta of 0.95. The company has a quick ratio of 2.55, a current ratio of 2.91 and a debt-to-equity ratio of 0.37. The company’s 50 day simple moving average is $292.37 and its 200-day simple moving average is $289.08.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last announced its quarterly earnings results on Friday, May 10th. The biotechnology company reported $1.15 earnings per share for the quarter, beating the consensus estimate of $0.95 by $0.20. The company had revenue of $460.74 million during the quarter, compared to analysts’ expectations of $441.57 million. Axon Enterprise had a return on equity of 11.71% and a net margin of 15.60%. The firm’s quarterly revenue was up 34.3% compared to the same quarter last year. During the same period in the previous year, the business earned $0.51 earnings per share. Analysts forecast that Axon Enterprise, Inc. will post 2.35 EPS for the current year.
Axon Enterprise Profile
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Recommended Stories
- Five stocks we like better than Axon Enterprise
- ETF Screener: Uses and Step-by-Step Guide
- Is This Telehealth Stock a Buy After the Recent Pullback?
- Stock Splits, Do They Really Impact Investors?
- Safeguard Against Credit Card Risks with This Top Financial Stock
- What Investors Need to Know to Beat the Market
- Streaming Titan’s Stock Ready to Hit All-Time Highs This Year
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.